Company Filing History:
Years Active: 2024
Title: Austin Chen: Innovator in Neurological Therapeutics
Introduction
Austin Chen is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the muscarinic acetylcholine receptor M1. His work is crucial for advancing treatments for neurological and psychiatric disorders.
Latest Patents
Austin Chen holds a patent for muscarinic acetylcholine receptor antagonists. This patent includes compounds that serve as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1). The patent also details synthetic methods for creating these compounds, pharmaceutical compositions that incorporate them, and methods for treating disorders associated with muscarinic acetylcholine receptor dysfunction.
Career Highlights
Austin is currently employed at Contineum Therapeutics, Inc., where he continues to innovate in the field of therapeutic compounds. His work is characterized by a commitment to improving treatment options for patients suffering from various neurological conditions.
Collaborations
Austin collaborates with notable colleagues, including Thomas Schrader and Yifeng Xiong. Their combined expertise enhances the research and development efforts at Contineum Therapeutics, Inc.
Conclusion
Austin Chen is a dedicated inventor whose work in muscarinic acetylcholine receptor antagonists holds promise for the future of neurological and psychiatric treatment. His contributions are paving the way for innovative solutions in healthcare.